Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

Clinical trial NCT03291249 · WITHDRAWN

Trial details

NCT number: NCT03291249
Sponsor: Tiziana Life Sciences LTD
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

NASH - Nonalcoholic Steatohepatitis NAFLD T2DM (Type 2 Diabetes Mellitus)

Start date: 2017-12-01
Primary completion: 2018-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.